Back to Journals » Drug Design, Development and Therapy » Volume 14

Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age

Total article views   HTML views PDF downloads Totals
10,737 Dovepress* 8,971+ 1,286 10,257
PubMed Central* 1,766 754 2,520
Totals 10,737 2,040 12,777
*Since 3 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar